IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in IGC Pharma, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- 0 vs. Q1 2023
- Shares held
- 2.65M
- −51.9K (−1.9%) vs. Q1 2023
- Total value
- $827.5K
- −$90.1K (−9.8%) vs. Q1 2023
- New holders
- 1
- 4 more added
- Sold out
- 1
- 5 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IGC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $1.41M |
| Q1 2026 | 35 | $1.14M |
| Q4 2025 | 30 | $1.36M |
| Q3 2025 | 35 | $2.27M |
| Q2 2025 | 28 | $929.4K |
| Q1 2025 | 25 | $814.9K |
| Q4 2024 | 30 | $954.3K |
| Q3 2024 | 23 | $1.19M |
| Q2 2024 | 25 | $1.11M |
| Q1 2024 | 25 | $943.4K |
| Q4 2023 | 25 | $691.3K |
| Q3 2023 | 27 | $1.01M |
| Q2 2023 | 23 | $827.5K |
| Q1 2023 | 23 | $917.6K |
| Q4 2022 | 26 | $937.3K |
| Q3 2022 | 26 | $1.31M |
| Q2 2022 | 29 | $1.73M |
| Q1 2022 | 29 | $3.97M |
| Q4 2021 | 29 | $6.07M |
| Q3 2021 | 32 | $7.90M |
| Q2 2021 | 29 | $7.90M |
| Q1 2021 | 29 | $7.97M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding IGC Pharma, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 755,786 | $235.5K | 0.00% | −760.0% | Reduced |
| Vanguard Group Inc | 646,543 | $201.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 302,140 | $94.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 184,107 | $57.4K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 162,709 | $51.0K | 0.00% | +52,409+47.5% | Added |
| Dearborn Partners LLC | 116,710 | $36.4K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 75,158 | $23.4K | 0.00% | −13,564−15.3% | Reduced |
| Northern Trust Corp | 71,364 | $22.2K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 69,000 | $21.5K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 65,513 | $20.4K | 0.00% | +100.0% | Added |
| Group One Trading, L.P. | 59,972 | $18.7K | 0.00% | −184−0.3% | Reduced |
| Commonwealth Equity Services, LLC | 53,156 | $17.0K | 0.00% | 00.0% | Unchanged |
| Truist Financial Corp | 36,667 | $11.4K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 20,681 | $6.45K | 0.00% | −114−0.5% | Reduced |
| Two Sigma Securities, LLC | 15,444 | $4.81K | 0.00% | +15,444 | New |
| Millennium Management LLC | 13,292 | $4.14K | 0.00% | −90,491−87.2% | Reduced |
| Geneos Wealth Management Inc. | 3,000 | $930 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 810 | $252 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 356 | $111 | 0.00% | +15+4.4% | Added |
| UBS Group AG | 294 | $92 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 250 | $78 | 0.00% | +230+1,150.0% | Added |
| Advisor Group Holdings, Inc. | 232 | $72 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 6 | $0 | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,610−100.0% | Sold out |